This activity is supported by an independent educational grant from Portola Pharmaceuticals.

Eric Howell, MD, MHM

Scott Kaatz, DO, MSc, SFHM

Steve Deitelzweig, MD, SFHM

Paul Grant, MD, SFHM

Summary

The world of anticoagulation management is complex. Pharmaceutical breakthroughs in the last few years have created a myriad of questions and protocols for practitioners to consider. In this changing landscape rapid changes create a gap between current and optimal care and professional education is key for bridging that gap.

In an October 2016 survey of 45 SHM chapter leaders, 51 percent of respondents selected “VTE and Anticoagulation Updates” as a top priority, ranking it the sixth-most important topic out of nineteen available options.

Goal

Provide timely, relevant education centered on key issues of VTE prevention in the hospitalized medically ill (non-surgical) patient.

Target Audience

This activity is designed for hospitalists, nurse practitioners, and physician assistants.

Learning Objectives

After completing the module, the participant will demonstrate the ability to:

1. Appreciate the American College of Physicians (ACCP) guidelines to perform venous thromboembolism (VTE) risk assessment in hospitalized medical ill patients.
2. Know how to apply VTE risk assessment models to aid in identifying at risk patients
3. Identify patients at-risk for VTE and determine the appropriate prophylactic approach at the time of admission and throughout hospitalization.
4. Be able to identify patients that do not need VTE prophylaxis
5. Appreciate the risk and benefit of extended VTE prophylaxis after hospital discharge and identify appropriate patients

Accreditation Statement 

The Society of Hospital Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Statement Designation

The Society of Hospital Medicine designates this activity for a maximum of 1 AMA PRA Category 1 Credit(s)^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Release Date: 9/04/2018  Expiration Date: 9/04/2021

Conflict of Interest Disclosure Policy

In accordance with the ACCME Standards for Commercial Support, SHM requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. SHM resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. All relevant financial relationships shall be disclosed to participants prior to the start of the activity.

Furthermore, SHM seeks to verify that all scientific research referred to, reported, or used in a continuing medical education (CME) activity conforms to the generally accepted standards of experimental design, data collection, and analysis. SHM is committed to providing its learners with high-quality CME activities that promote improvements in healthcare and not those of a commercial interest.

Instructions

The following is an educational module designed to help provide timely, relevant education centered on key issues of VTE prevention in the hospitalized medically ill (non-surgical) patient. It consists of 5 sections: 4 video-based lectures, and a CME evaluation. 

While the videos are presented in a linear outline, participants may watch them in any order, and may skip videos that are less applicable.